Thyrocare
Presence
PharmEasy is one of the...
They are in:
- Retail50%
- Biotechnology50%
Acquisition, funding and merger involving PharmEasy.
- PharmEasy has just announced a $300 Million fundraising (posted on September 13 2022).
- PharmEasy has just announced a $200 Million fundraising (posted on July 19 2022).
Executives
View the org chart displaying its 3 main executives
Most searched biographies at Thyrocare
- Arokiaswamy Velumani, Chairman and Managing Director and Chief Exe...
- Alok Jagnani, Chief Financial Officer
- Nitin Chugh, Chief Commercial Officer
Popular executive movements at Thyrocare
- Nitin Chugh has joined the company as Chief Commercial Officer (posted on February 25 2024).
Create your alert
to follow the executive moves at Thyrocare.
Biotechnology
PharmEasy has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by Thyrocare
Social media about Thyrocare
- Thyrocare on Wikipedia, Google News & Yahoo Finance
- Thyrocare on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Alok Jagnani 
